Top Glove (TOPGLOV) Q4 2024 earnings summary

Executive summary

• Achieved highest post-pandemic sales volume growth in 4QFY24, with a 91% YoY and 31% QoQ increase in sales volume, and revenue up 75% YoY and 31% QoQ.

• EBITDA turned positive at RM251 million for FY2024, a 261% YoY improvement, with net loss narrowing to RM18 million from RM886 million in FY2023.

• Strong U.S. sales growth driven by FDA import alerts and anticipation of higher U.S. tariffs on China-made gloves, with U.S. market sales volume up 120% QoQ.

• Improved operational efficiency and cost management, though profitability was impacted by a sudden weakening of the USD.

• Enhanced cash position through asset disposals and preparation for perpetual sukuk redemption.

Financial highlights

• 4QFY24 revenue rose to RM835 million (+31% QoQ, +75% YoY); FY2024 revenue increased 11% YoY to RM2,516 million.

• FY2024 EBITDA improved to RM251 million from a loss of RM562 million in FY2023.

• FY2024 net loss narrowed significantly to RM18 million from RM886 million in FY2023; 4QFY24 profit after tax reached RM8 million.

• 4QFY24 core net loss widened to RM34 million due to forex losses and refurbishment costs.

• No dividend declared for FY2024; dividend policy of 50% PATAMI maintained.

Outlook and guidance

• Strong glove demand expected to persist, supported by U.S. tariffs on Chinese imports and ongoing stock replenishment.

• Higher ASPs anticipated as prices are adjusted to reflect increased raw material costs.

• Higher utilization rates and expanded capacity (up to 64 billion pieces by December 2024) to improve margins.

• Installation of advanced production lines to resume, but capacity expansion remains cautious due to market volatility.

• Confident of returning to profitability in FY2025.